Establishment of a pseudovirus neutralization assay for TGEV

Establishment of a pseudovirus neutralization assay for TGEV

IntroductionTransmissible Gastroenteritis Virus (TGEV) is a major pathogen causing swine enteric diseases, necessitating effective control strategies. Vaccination plays a key role, but assessing vaccine efficacy remains challenging due to variations in immune response and existing detection limitati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haojie Wang, Jianxing Chen, Lihong Xue, Yue Sun, Tongqing An, Yue Wang, Hongyan Chen, Changqing Yu, Changyou Xia, He Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Immunology
Subjects:	TGEV pseudovirus neutralizing antibody pseudovirus neutralization test ST cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1558604/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
by: Jianhui Nie, et al.
Published: (2020-01-01)

HIV-1 pseudoviruses constructed in China regulatory laboratory
by: Jianhui Nie, et al.
Published: (2020-01-01)

Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient
by: Yanan Wu, et al.
Published: (2024-11-01)

Four-Color Pseudovirus-Based Neutralization Assay: A Rapid Method for Evaluating Neutralizing Antibodies Against Quadrivalent Hand, Foot, and Mouth Disease Vaccine
by: Fan Gao, et al.
Published: (2025-03-01)

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector
by: Ziteng Liang, et al.
Published: (2023-12-01)

Env-pseudoviruses based on the HIV-1 genetic variant circulating in Siberia
by: N. B. Rudometova, et al.
Published: (2025-07-01)

Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains
by: Xiande Huang, et al.
Published: (2024-12-01)

Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes
by: Sabari Nath Neerukonda, et al.
Published: (2025-03-01)

Development and characterization of a pseudovirus system for human Aichi virus: in vitro and in vivo analysis
by: Ruojun Wu, et al.
Published: (2025-07-01)

Multiple Mechanisms of HIV-1 Resistance to PGT135 in a Chinese Subtype B’ Slow Progressor
by: Yuanyuan Hu, et al.
Published: (2025-06-01)

A Bioluminescent Imaging Mouse Model for Seasonal Influenza Virus Infection Based on a Pseudovirus System
by: Yifei Wang, et al.
Published: (2025-05-01)

Deltacoronavirus HKU11, HKU13, PDCoV (HKU15) and HKU17 spike pseudoviruses enter avian DF-1 cells via clathrin-mediated endocytosis in a Rab5-, Rab7- and pH-dependent manner
by: Qi-Zhang Liang, et al.
Published: (2025-01-01)

Improvement on Ferrous Ion Accumulation and Mitochondrial Dysfunction in the COVID-19 Pseudovirus-Infected Cell Model Simulating the Long COVID Status by Nutritional Strategy
by: Bo-Kai Chen, et al.
Published: (2025-06-01)

Retrovirus-based pseudotyped virus neutralisation assays overestimate neutralising activity in sera from participants receiving integrase inhibitors
by: Mhairi J. McCormack, et al.
Published: (2025-08-01)

Establishment of a One–Pot RAA–CRISPR/Cas13a Assay-Based TGEV S Gene Detection
by: Lindan Lv, et al.
Published: (2025-05-01)

The COPII Transport Complex Participates in HPV16 Infection
by: Patricia M. Day, et al.
Published: (2025-04-01)

Development of a neutralization assay and bioluminescent imaging mouse model for Dehong virus (DEHV) using a pseudovirus system
by: Xuelian Wu, et al.
Published: (2025-05-01)

Development of a novel pseudovirus-based quality control material for HIV-1 nucleic acid testing and its application in external quality assessment
by: Di Han, et al.
Published: (2025-07-01)

Transmissible Gastroenteritis Virus (TGEV) and Porcine Respiratory Coronavirus (PRCV): Epidemiology and Molecular Characteristics—An Updated Overview
by: Monika Olech, et al.
Published: (2025-03-01)

The Pseudotyped Replication-Deficient VSV with Spike from PEDV Induces Neutralizing Antibody Against PEDV
by: Jingxuan Yi, et al.
Published: (2025-02-01)

Inactivation of Pseudovirus Expressing the D614G Spike Protein Mutation using Nitric Oxide‐Plasma Activated Water
by: Paritosh Patel, et al.
Published: (2024-12-01)

Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
by: Muntasir Alam, et al.
Published: (2025-07-01)

The effect of beta-globin intron and WPRE on transient expression of SARS-CoV-2 spike and generation of pseudotyped lentiviruses
by: Hyeop Jin, et al.
Published: (2025-04-01)

In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells
by: Alberta Serwaa, et al.
Published: (2024-10-01)

Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species
by: Leira Fernández-Bastit, et al.
Published: (2025-05-01)

Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants
by: Wenbo Wang, et al.
Published: (2021-01-01)

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus
by: Ya-Li Zhang, et al.
Published: (2019-01-01)

CoreTIA: a modular, statistically robust transduction inhibition assay for AAV neutralization
by: Beatrix Kovács, et al.
Published: (2025-08-01)

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
by: Benjamin Meyer, et al.
Published: (2020-01-01)

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection
by: Xinlin Liu, et al.
Published: (2019-01-01)

Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities
by: Jianhui Nie, et al.
Published: (2019-01-01)

Defining criteria for broadly neutralizing HIV antibodies
by: Elizabeth-Sharon David-Fung, et al.
Published: (2025-07-01)

Remapping the spatial distribution of neutralizing sites and their immunodominance on the capsid of different topotypes of FMDV serotype O by site-directed competitive ELISA for detection of neutralizing antibodies
by: Qiongqiong Zhao, et al.
Published: (2025-06-01)

A Comprehensive Evaluation of the HPV Neutralizing Antibodies in Guangzhou, China: A Comparative Study on Various HPV Vaccines
by: Renyun Zha, et al.
Published: (2024-11-01)

THE NEUTRALITY OF THE REPUBLIC OF BELARUS AS LEGAL PROVISION
by: O. I. Chupris, et al.
Published: (2018-04-01)

Development and Validation of the ELISA Method for Neutralizing Anti-trastuzumab Antibodies Detection in Human Blood Serum
by: M. A. Kolganova, et al.
Published: (2023-05-01)

Differential Neutralization Profiles of 17DD Vaccinated Population to 17D-204 and 17DD Vaccine Strains
by: Ana C. B. Terzian, et al.
Published: (2024-11-01)

Net Neutrality and 5G in India: A Policy Delphi Survey
by: Anuradha Mitra, et al.
Published: (2024-10-01)

Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
by: Kexuan Cheng, et al.
Published: (2024-12-01)

Retinal Epithelial Neutralization Assay Optimizes AAV Serotype Selection for Ocular Gene Therapy
by: Yao Li, et al.
Published: (2025-07-01)